Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Epizyme, Inc. (EPZM)

« Back to company index

EPZM Chatter Timeline

Stock Ticker for EPZM

Most Active Tweeters for EPZM

UserTweets
@1MinuteStock 17
@Tickeron 12
@stockmktgenius 10
@Lin_ling_88 10
@newsfilterio 7

Recent Tweets for EPZM

sikorsj @sikorsj
RT @EpizymeRx: #Breaking: @US_FDA grants accelerated approval to $EPZM’s first #oncology product. Read more: https://t.co/G3LKg8WvWD https:…
7:01pm
touchraazu1 @touchraazu1
RT @marvinador: Stock to watch tomorrow: $EPZM #stock #fdaapproval #biotech https://t.co/oFVQQXhv8C
6:01pm
jeff_cranmer @jeff_cranmer
13 yrs since its founding, $EPZM now has an approved drug, Tazverik tazemetostat, a first-in-class EZH2 inhibitor t… https://t.co/GpR5JRzaQ4
6:01pm
marvinador @marvinador
Stock to watch tomorrow: $EPZM #stock #fdaapproval #biotech https://t.co/oFVQQXhv8C
6:01pm
Lin_ling_88 @Lin_ling_88
$EPZM #OncLive commented on #tazemetostat’s accelerated approval: https://t.co/i2vjgceOfc
6:01pm
MarketCurrents @MarketCurrents
$EPZM - FDA approves Epizyme's treatment for epithelioid sarcoma https://t.co/CxAnNyIVne
6:01pm
OlympiaReport @OlympiaReport
Epizyme $EPZM Shares Gap Up Following Analyst Upgrade https://t.co/JG6k8mculs
6:01pm
dispatchtribune @dispatchtribune
Epizyme $EPZM Shares Gap Up After Analyst Upgrade https://t.co/AB8VR8D9T5
6:01pm
realmaciej @realmaciej
RT @odibro: $EPZM Announces FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma ht…
6:01pm
jonathanrockoff @jonathanrockoff
$EPZM wins @US_FDA approval for its rare, soft tissue cancer drug Tazverik, agency says
6:01pm
seculare @seculare
RT @seculare: @MadMoneyOnCNBC $EPZM Tazemetostat is poised for approval this month & expanded approval later this year. With a promising pi…
6:01pm
LizCancerHealth @LizCancerHealth
RT @NedPagliarulo: $EPZM's tazemetostat approved by FDA for epithelioid sarcoma. Will be sold as Tazverik. Call at 5:30 PM ET https://t.c…
6:01pm
BosBizAllison @BosBizAllison
@EpizymeRx It's worth noting that $EPZM has said the drug — which is also awaiting FDA approval as a treatment for… https://t.co/BcTEvX7OYR
5:01pm
piealamo @piealamo
This is it??????? $EPZM
5:01pm
PinkSheetSutter @PinkSheetSutter
@US_FDA grants accelerated approval to $EPZM's Tazverik (tazemetostat) for epithelioid sarcoma, in line w/ unanimou… https://t.co/ZtbMeP4Dnu
5:01pm
NedPagliarulo @NedPagliarulo
Price for $EPZM's tazemetostat is $15,500 for one month supply, per conference call.
5:01pm
BosBizAllison @BosBizAllison
Breaking: @EpizymeRx's first-ever commercial product for a rare cancer has been approved. It will cost $15,500 per month. $EPZM
5:01pm
stockmktgenius @stockmktgenius
$EPZM Epizyme, Inc. - Common St Top stock up 197% from low. Close: 26.72 VolvsAvg: 1.49 Liq: $50M https://t.co/IRQ3Smj1B8
5:01pm
TraderMorty @TraderMorty
RT @zipcharlie: $EPZM gets approved - BUT remember, every reaction is an overreaction. Proceed with caution... #trading https://t.co/UMH6LE…
5:01pm
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $EPZM is $-0.67 it's -2.63% of the current price https://t.co/Xq2g1XlI9e
5:01pm
medtechy @medtechy
Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK $EPZM | Medtechy https://t.co/YD5vkLJYSu
5:01pm
vernon_veegray1 @vernon_veegray1
$EPZM Wasn’t this suppose to go to the moon or something of that nature?
5:01pm
Lin_ling_88 @Lin_ling_88
FDA approves Epizyme's treatment for rare tissue cancer - Reuters $EPZM #tazemetostat approved for epithelioid sar… https://t.co/kUTcGtph9B
5:01pm
syinvesting @syinvesting
$EPZM Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients wit… https://t.co/y7tqodB3S7
5:01pm
haodongvli @haodongvli
$EPZM was a crowded short last year https://t.co/RsO4bNFjYT
5:01pm
otcdynamics @otcdynamics
$EPZM Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients w https://t.co/85jONmNMJp
5:01pm
eo1989 @eo1989
RT @TraderTexMex: $EPZM Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epit…
5:01pm
zipcharlie @zipcharlie
$EPZM gets approved - BUT remember, every reaction is an overreaction. Proceed with caution... #trading https://t.co/UMH6LEVMO1
5:01pm
NedPagliarulo @NedPagliarulo
$EPZM's tazemetostat approved by FDA for epithelioid sarcoma. Will be sold as Tazverik. Call at 5:30 PM ET https://t.co/wo9inKP8bh
5:01pm
TraderTexMex @TraderTexMex
$EPZM Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma
5:01pm
odibro @odibro
$EPZM Announces FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid… https://t.co/BcXLGVESqq
5:01pm
ScorpioRysing @ScorpioRysing
@Lin_ling_88 $EPZM - Hmm, if so, that doesn't bode well. Hoping they get approval, but no dog in this show myself. GLTA.
4:01pm
Lin_ling_88 @Lin_ling_88
$EPZM: @i am pretty sure FDA has informed Epizyme of its decision regarding #tazemetostat ‘s NDA, for reasons know… https://t.co/Og5eQeCBzS
4:01pm
androsForm @androsForm
$EPZM money flow chart via SuperStocks App https://t.co/D6orcLyUII
3:01pm
shane_adamski @shane_adamski
RT @zipcharlie: Keep an eye on $EPZM before the FDA decision! We talked about this guy back on Sunday & on the 22nd of Dec. I prefer disapp…
3:01pm
zipcharlie @zipcharlie
Keep an eye on $EPZM before the FDA decision! We talked about this guy back on Sunday & on the 22nd of Dec. I prefe… https://t.co/FF55vwzuJK
3:01pm
1MinuteStock @1MinuteStock
Recommendation #HOLD for $EPZM with UB rating - 2.25 out of 5. https://t.co/LBzC2yV0n2
3:01pm
Tickeron @Tickeron
$EPZM in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/P6qg3WoCTQ
3:01pm
stockmonitorapp @stockmonitorapp
RSI just crossed above 70 on $EPZM. Gaining strength! See chart: https://t.co/Jsn3XT6Ffs $COMPQ https://t.co/pUB82Azff1
2:01pm
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $EPZM is $-0.67 it's -2.63% of the current price https://t.co/Xq2g1X47hG
2:01pm
haodongvli @haodongvli
$EPZM 52 wk high, who was selling below $10 a few month ago?
2:01pm
vernon_veegray1 @vernon_veegray1
$EPZM Alright!! Bought a few hundred shares and I’m losing money already!
2:01pm
birdmang30 @birdmang30
RT @Getrealorelse: $EPZM...fingers crossed...PDUFA today
2:01pm
Getrealorelse @Getrealorelse
$EPZM...fingers crossed...PDUFA today
2:01pm
1MinuteStock @1MinuteStock
Not sure what to do with $EPZM? Explore our #fundamental pros and cons. https://t.co/SnV0Tj9pZr
1:01pm
c2412345 @c2412345
$EPZM FDA approval after hours. Wonder if it will go +100% like $AUPH did ? Also a buyout target with a price as h… https://t.co/M5GKvHuyXN
1:01pm
TheUnicornBay @TheUnicornBay
Do you know that #WallStreet price for $EPZM is $22.63 https://t.co/gXEDFWfyV9
1:01pm
OphirGottlieb @OphirGottlieb
$EPZM Epizyme shares are trading higher after Citigroup maintained its Buy rating on the stock and raised its price… https://t.co/dZDi1Tq987
10:01am
aboutheoptions @aboutheoptions
Trade Ideas $EPZM (delayed) FEB21 30C/20P #strangle - still actionable
9:01am
JosePon86089208 @JosePon86089208
$EPZM - Citigroup Maintains Buy on Epizyme, Raises Price Target to $35
9:01am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.